These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22118163)
1. Contact tracing in low-incidence tuberculosis settings. van Leth F; Borgdorff M Int J Tuberc Lung Dis; 2011 Dec; 15(12):1566. PubMed ID: 22118163 [No Abstract] [Full Text] [Related]
2. Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study. Gupta RK; Kunst H; Lipman M; Noursadeghi M; Jackson C; Southern J; Imran A; Lozewicz S; Abubakar I Ann Am Thorac Soc; 2020 May; 17(5):646-650. PubMed ID: 32083944 [No Abstract] [Full Text] [Related]
3. Usefulness of Interferon-gamma Release Assays in the Screening of Latent Tuberculosis Infection in Immigrant and Internationally Adopted Children. Méndez-Echevarría A; Sainz T; García-Hortelano M; Baquero-Artigao F; Mellado MJ Pediatr Infect Dis J; 2015 Oct; 34(10):1141-2. PubMed ID: 26367809 [No Abstract] [Full Text] [Related]
4. Tuberculin skin test and/or interferon gamma release assay: is it still time to debate? Sanduzzi A; Marchetiello I; Bocchino M; Boccia G; De Caro F Infez Med; 2017 Mar; 25(1):80-81. PubMed ID: 28353462 [TBL] [Abstract][Full Text] [Related]
5. Testing International Adoptees for Tuberculosis. Priya Dhar C; Elena Gonzalez B; Dragga T; Bothe D; Mandalakas AM Pediatr Infect Dis J; 2015 Oct; 34(10):1138-9. PubMed ID: 26367807 [No Abstract] [Full Text] [Related]
6. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents. So H; Yuen CS; Yip RM Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971 [TBL] [Abstract][Full Text] [Related]
8. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Barcellini L; Borroni E; Brown J; Brunetti E; Campisi D; Castellotti PF; Codecasa LR; Cugnata F; Di Serio C; Ferrarese M; Goletti D; Lipman M; Rancoita PM; Russo G; Tadolini M; Vanino E; Cirillo DM Eur Respir J; 2016 Nov; 48(5):1411-1419. PubMed ID: 27390280 [TBL] [Abstract][Full Text] [Related]
9. End TB Strategy: Time to Move on From the Skin Test to the Interferon- Kruse M; Cruikshank W Am J Public Health; 2019 Aug; 109(8):1102-1104. PubMed ID: 31268768 [No Abstract] [Full Text] [Related]
10. Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea. Kim HJ; Lee GH; Ryoo S; Oh SY; Lee JB; Kim JH; Shin C; Lee SH Int J Tuberc Lung Dis; 2015 May; 19(5):576-81. PubMed ID: 25868027 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Latent Tuberculosis Infection: Too Soon to Pull the Plug on the Tuberculin Skin Test. Collins LF; Geadas C; Ellner JJ Ann Intern Med; 2016 Jan; 164(2):122-4. PubMed ID: 26642354 [No Abstract] [Full Text] [Related]
12. Screening for Latent Tuberculosis Infection: A Key Step Toward Achieving Tuberculosis Elimination in the United States. Reves R; Daley CL JAMA Intern Med; 2016 Oct; 176(10):1439-1440. PubMed ID: 27599130 [No Abstract] [Full Text] [Related]
13. Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities. Grinsdale JA; Ho CS; Banouvong H; Kawamura LM Int J Tuberc Lung Dis; 2011 Dec; 15(12):1614-20. PubMed ID: 22118167 [TBL] [Abstract][Full Text] [Related]
14. Advances in the diagnosis of latent tuberculosis infection. Schluger NW Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006 [TBL] [Abstract][Full Text] [Related]
15. Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Mandalakas AM; Kirchner HL; Walzl G; Gie RP; Schaaf HS; Cotton MF; Grewal HM; Hesseling AC Am J Respir Crit Care Med; 2015 Apr; 191(7):820-30. PubMed ID: 25622087 [TBL] [Abstract][Full Text] [Related]
16. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country. Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G; Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798 [TBL] [Abstract][Full Text] [Related]
17. [Risk of tuberculosis in healthcare workers: risk assessment and medical surveillance]. Magrini A; Coppeta L; Somma G; Neri A; Gentili S; Fiocco G; Pietroiusti A Ig Sanita Pubbl; 2016; 72(2):137-43. PubMed ID: 27336958 [TBL] [Abstract][Full Text] [Related]
18. Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study. Roth DZ; Ronald LA; Ling D; Chiang LY; Cook VJ; Morshed MG; Johnston JC Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331032 [No Abstract] [Full Text] [Related]
19. Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana. Mensah GI; Sowah SA; Yeboah NY; Addo KK; Jackson-Sillah D Int J Mycobacteriol; 2017; 6(1):27-33. PubMed ID: 28317801 [TBL] [Abstract][Full Text] [Related]
20. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy. Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]